Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to -$20.4 million.

  • Macrogenics' Cash from Investing Activities fell 15722.35% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year decrease of 10452.77%. This contributed to the annual value of $149.3 million for FY2024, which is 28642.55% up from last year.
  • Macrogenics' Cash from Investing Activities amounted to -$20.4 million in Q3 2025, which was down 15722.35% from -$37.6 million recorded in Q2 2025.
  • Macrogenics' 5-year Cash from Investing Activities high stood at $71.9 million for Q3 2022, and its period low was -$113.5 million during Q2 2023.
  • Over the past 5 years, Macrogenics' median Cash from Investing Activities value was $9.9 million (recorded in 2025), while the average stood at $2.9 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 284917.84% in 2022, then crashed by 59253.87% in 2023.
  • Quarter analysis of 5 years shows Macrogenics' Cash from Investing Activities stood at -$13.6 million in 2021, then skyrocketed by 57.29% to -$5.8 million in 2022, then skyrocketed by 770.73% to $38.8 million in 2023, then increased by 6.81% to $41.5 million in 2024, then crashed by 149.13% to -$20.4 million in 2025.
  • Its Cash from Investing Activities was -$20.4 million in Q3 2025, compared to -$37.6 million in Q2 2025 and $9.9 million in Q1 2025.